00002-4165 Evista - CanMED: NDC

Product NDC:

00002-4165

Brand Name:

Evista

Generic Name:

Raloxifene Hydrochloride

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Raloxifene Hydrochloride

Strength: 60.0

Unit: mg/1

Packages:

Code: 00002-4165-02

Description: 100 TABLET in 1 BOTTLE (0002-4165-02)

Effective Date: Jan. 6, 1998

Discontinued: Dec. 31, 2017

Code: 00002-4165-07

Description: 1 BOTTLE in 1 CARTON (0002-4165-07) > 2000 TABLET in 1 BOTTLE

Effective Date: Jan. 6, 1998

Discontinued: Nov. 30, 2017

Code: 00002-4165-30

Description: 30 TABLET in 1 BOTTLE (0002-4165-30)

Effective Date: Jan. 6, 1998

Discontinued: Jan. 31, 2018

Code: 00002-4165-34

Description:

Effective Date: Jan. 6, 1998

Discontinued: Jan. 25, 2011

Code: 00002-4165-61

Description:

Effective Date: June 10, 2010

Discontinued: April 3, 2015

Code: 00002-4165-79

Description:

Effective Date: Jan. 6, 1998

Discontinued: Jan. 25, 2011

Code: 00002-4165-99

Description:

Effective Date: Aug. 6, 2009

Discontinued: March 5, 2012

SEER*Rx Category:

Hormonal Therapy

Major Class:

Selective Estrogen Receptor Modulator (SERM)

Minor Class:

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox

CanMED: NDC